Evaluation of Ovarian Reserve and Function in Female Patients Treated with Oral Isotretinoin for Severe Acne: An Exploratory Study

    March 2014 in “ Cutaneous and Ocular Toxicology ”
    Savaş Öztürk, Tulin Ozturk, Haydar Uçak, Ilker Erden, Betül Demir, Alperen Kayali, Demet Cicek
    New to Estradiol? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that while isotretinoin lowered levels of female hormones in patients with severe acne, it did not significantly impact ovarian reserve function. Our plain-language summary of this paper — not a Tressless recommendation.
    In a 2014 exploratory study of 32 female patients with severe acne, the effects of oral isotretinoin on ovarian reserve and hormone levels were assessed. Patients were treated with 0.5-2 mg/kg/day of isotretinoin for 5 to 8 months, totaling a cumulative dose of 120-135 mg/kg. Measurements of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), antral follicle count (AFC), and ovarian volume (OV) were taken before and after treatment. The study found significant decreases in FSH, LH, and E2 levels after treatment, but no significant changes in AFC and OV, suggesting that while isotretinoin affects hormone levels, it does not significantly impact ovarian function in these patients. Limitations included the use of transabdominal ultrasonography and the inability to assess anti-Mullerian hormone.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results